Rezultati - Е. V. Raykina
- Showing 1 - 3 results of 3
-
1
Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β– and CD19-Depleted Grafts od Alexandra Laberko, Anna Bogoyavlenskaya, Лариса Шелихова, Zhanna Shekhovtsova, Dmitry Balashov, K. A. Voronin, Elena Kurnikova, Elena Boyakova, Е. V. Raykina, В. В. Бриллиантова, Valentina Pirumova, Галина Новичкова, Alexei Maschan, Michael Maschan
Izdano 2016Artigo -
2
Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy:... od Ekaterina Mikhailova, Alexandra Semchenkova, Olga Illarionova, S. A. Kashpor, В. В. Бриллиантова, Елена Захарова, Elena Zerkalenkova, Andrea Zangrando, N. G. Bocharova, Лариса Шелихова, Yulia Diakonova, Vladimir Zhogov, Rimma Khismatullina, Olga Molostova, Barbara Buldini, Е. V. Raykina, Sergey S. Larin, Yulia Olshanskaya, Natalia Miakova, Galina Novichkova, Michael Maschan, А. М. Попов
Izdano 2021Artigo -
3
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH od D. A. Evseev, D. S. Osipova, И. И. Калинина, Е. V. Raykina, Anna Ignatova, E. I. Lyudovskikh, Dina Baidildina, А. М. Попов, Vladimir Zhogov, Alexandra Semchenkova, Е. А. Литвин, N. N. Kotskaya, E. A. Cherniak, K. A. Voronin, E. A. Burtsev, Г. О. Бронин, Iulia Vlasova, Б. Б. Пурбуева, O. S. Fink, Е. А. Пристанскова, Irina Dzhukaeva, Elena Erega, Галина Новичкова, Alexey Maschan, Michael Maschan
Izdano 2023Artigo
Iskalna orodja:
Sorodne teme
Medicine
Gastroenterology
Immunology
Internal medicine
Antibody
Antigen
B cell
Blinatumomab
CD19
Cancer
Cancer research
Chemotherapy
Chimeric antigen receptor
Cladribine
Concomitant
Confidence interval
Cumulative incidence
Cytarabine
Cytomegalovirus
Disease
Flow cytometry
Hazard ratio
Hematopoietic stem cell transplantation
Herpesviridae
Immune system
Langerhans cell histiocytosis
Leukemia
Lymphoma
Metastatic melanoma
Minimal residual disease